Cost of developing new drugs may be far lower than industry claims, trial reveals
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies
James Anderson Thomas Nyangwa Roz Scourse International Federation Of Pharmaceutical Manufacturers World Health Organization Drug Administration
Source: theguardian.com